Navigation Links
ResMed Inc. Announces Record Financial Results for the Quarter Ended and Nine Months Ended March 31, 2011
Date:4/28/2011

ine months ended March 31, 2011, revenue was $901.3 million, an increase of 13% over the nine months ended March 31, 2010 (a 14% increase on a constant currency basis).  For the nine months ended March 31, 2011, income from operations and net income were $200.2 million and $168.5 million, an increase of 17% and 23%, respectively, compared to the nine months ended March 31, 2010.  Diluted earnings per share for the nine months ended March 31, 2011 were $1.07 per diluted share, an increase of 20% compared to the nine months ended March 31, 2010.

Inventory, at $205.0 million, increased by $19.4 million compared to June 30, 2010.  Accounts receivable days sales outstanding, at 68 days, decreased by 3 days compared to June 30, 2010.  

Peter C. Farrell PhD, Chairman and Chief Executive Officer, commented, "In the third quarter of fiscal 2011 we continued to show strong year-over-year growth especially in Europe and the Asia-Pacific region.  Revenue outside the Americas increased by 16% to $152.7 million over the prior year's quarter, or a 15% increase on a constant currency basis.
Revenue in the Americas increased by over 9% to $160.5 million over the prior year's quarter. Americas' revenues continued to be adversely impacted by reduced bilevel sales, but we expect that the recent launch of the S9™ bilevel series will help to reverse this trend. Worldwide, our growth in flow generators was mainly driven by sales of the S9 AutoSet™.  Patient interface sales did extremely well in all regions. With the recent launches of the Quattro™ FX full face mask and the Mirage™ FX nasal mask, we have completed the release of the trilogy of masks in the FX series.  Operating profit for the March quarter was $64.0 million and cash flow from operations was a record $81.4 million, demonstrating excellent operating performance.

"We expect the growth of all our products to continue to benefit from the vastly
'/>"/>

SOURCE ResMed Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6

Related medicine technology :

1. ResMed Acquires Laboratoires Narval
2. ResMed Inc Announces Record Financial Results for the Quarter and Six Months Ended December 31, 2009
3. ResMed Inc. Announces Record Financial Results for the Quarter Ended September 30, 2009
4. ResMed Inc. to Present at Upcoming Conferences
5. ResMed Announces Deferred Conversions in Connection With Stock Split
6. ResMed Inc. Announces Completion of Two-for-One Stock Split
7. Study Shows ResMeds New CPAP Device Increases Patient Compliance
8. ResMed Announces Conference Call and Webcast to Discuss First Quarter 2011 Results
9. ResMed Inc. Announces Record Financial Results for the Quarter Ended September 30, 2010
10. ResMed Announces Conference Call and Webcast to Discuss Second Quarter 2011 Results
11. ResMed Inc. Announces Record Financial Results for the Quarter Ended and Six Months Ended December 31, 2010
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/23/2015)... , Jan. 23, 2015 Tianyin Pharmaceutical Inc. ... that specializes in the development and sale of patented ... and active pharmaceutical ingredients (API) today announced the business ... API operation. 1. Following the September 2014 ...
(Date:1/22/2015)... ON , Jan. 22, 2015 /PRNewswire/ - Pivotal Therapeutics Inc. ... with a focus on Omega-3 therapies for cardiovascular disease and ... of the Company,s accomplishments in 2014 and its outlook for ... Dear Fellow Shareholders, We would like to ...
(Date:1/22/2015)... , Jan. 22, 2015 Research and Markets ... "Infectious Disease Diagnostics Market by Product, Application, Technology, ... to their offering. , The infectious disease ... 7.9% to reach $18,156.2 million by 2019 from $12,422.8 ...
Breaking Medicine Technology:TPI's JCM Updates on Import Registration for International Clients 2TPI's JCM Updates on Import Registration for International Clients 3TPI's JCM Updates on Import Registration for International Clients 4Pivotal Therapeutics: Year in Review and CEO Update 2Pivotal Therapeutics: Year in Review and CEO Update 3Pivotal Therapeutics: Year in Review and CEO Update 4Pivotal Therapeutics: Year in Review and CEO Update 5Pivotal Therapeutics: Year in Review and CEO Update 6Pivotal Therapeutics: Year in Review and CEO Update 7Global Infectious Disease Diagnostics (Instruments, Reagents, Services, Software) Market - Forecast to 2019 2Global Infectious Disease Diagnostics (Instruments, Reagents, Services, Software) Market - Forecast to 2019 3
... BURLINGTON, Mass., Dec. 8, 2010 Decision Resources, ... firms for pharmaceutical and healthcare issues, finds that ... increasingly draconian drug pricing environment. While governments in ... the prices of most prescription drugs, their control ...
... Biopharma, a biopharmaceutical company developing both novel and ... announced that it has appointed Trevor Hallam, Ph.D., ... lead Sutro,s ongoing efforts in the application of ... the research and development of novel and biosuperior ...
Cached Medicine Technology:Government Regulation of Drug Prices will Increase in Both Mature and Emerging Markets, Including Markets that Traditionally Play a Limited Role in Pharmaceutical Pricing 2Government Regulation of Drug Prices will Increase in Both Mature and Emerging Markets, Including Markets that Traditionally Play a Limited Role in Pharmaceutical Pricing 3Sutro Biopharma Appoints Trevor Hallam, Ph.D., as Chief Scientific Officer 2
(Date:1/22/2015)... a famous wedding dress company offering many trendy designs. Today, ... Twitter, and Pinterest. The fans will have an opportunity to ... week. , Moreover, the company has extended its 2015 New ... for more information. , Angelweddingdress is a famous ...
(Date:1/22/2015)... the premier women’s dress supplier, has recently released its ... of AngelWeddingDress.com to find more details. , Many ... a bridal party. AngelWeddingDress offers a variety of gorgeous ... wedding dresses are specially designed for 2015. , AngelWeddingDress ...
(Date:1/22/2015)... 2015 Juvent Sports ( http://www.juventsports.com ) ... PGA Merchandise Show to bestow a Juvent Sports Achievement ... golfer, Arlene McKitrick. The award commemorated and congratulated McKitrick ... win. She won her first amateur tournament in 1979 ...
(Date:1/22/2015)... York (PRWEB) January 22, 2015 Thousand ... Fresenius Medical Care recalled its GranuFlo and NaturaLyte dialysis ... litigation underway in U.S. District Court, District of Massachusetts, ... January 20th, the Court has remanded a case filed ...
(Date:1/22/2015)... For over 20 years, Dr. David Cruz of ... area has treated just about every type of injury that ... And for those same twenty-plus years, the team at Doctors ... with the best possible doctor. With the combined breadth ...
Breaking Medicine News(10 mins):Health News:Angelweddingdress Invites Its Customers To Follow It On Facebook, Twitter, And Pinterest 2Health News:AngelWeddingDress Has Recently Released Its Collection Of 2015 Maternity Wedding Dresses 2Health News:All-Time Leading Female Amateur Golfer Arlene McKitrick Receives Juvent Sports Achievement Award at 2015 PGA Show 2Health News:All-Time Leading Female Amateur Golfer Arlene McKitrick Receives Juvent Sports Achievement Award at 2015 PGA Show 3Health News:Court Overseeing Federal GranuFlo Lawsuits Remands Louisiana Claim Back to State Court, Bernstein Liebhard LLP Reports 2Health News:Court Overseeing Federal GranuFlo Lawsuits Remands Louisiana Claim Back to State Court, Bernstein Liebhard LLP Reports 3Health News:Court Overseeing Federal GranuFlo Lawsuits Remands Louisiana Claim Back to State Court, Bernstein Liebhard LLP Reports 4Health News:Industry Leading Chiropractor in Oceanside Joins the Doctors on Liens Network 2
... NEW YORK , Feb. 17 As we ... office as Board President at the Jewish Board of Family and ... service to the agency.  "Giving of oneself is more than a ... larger than myself, such as JBFCS, has taught me the importance ...
... post-injury, researchers say , WEDNESDAY, Feb. 17 (HealthDay News) ... help assess whether athletes have suffered a concussion and ... , "Research has shown that reaction time is slower ... days after other symptoms have gone. But the tests ...
... 57,000 Americans face a diagnosis of kidney cancer each ... another treatment option. Physicians who conducted a pilot study ... before surgery with the drug sorafenib can reduce the ... administered without adding significantly to the risks of surgery. ...
... Pa. , Feb. 17 Elizabeth ... been named a 2010 Rising Star by the Healthcare ... in various sectors of the healthcare industry, including pharmaceutical, ... Nominated by HBA,s corporate members, Rising Stars represent diverse ...
... language paid attention to both, study found, , WEDNESDAY, ... languages spoken regularly during pregnancy might encourage babies to ... new study finds. , A team of psychological scientists ... Organization for Economic Cooperation and Development in France, watched ...
... published more than 40 years ago, Toole,s Cerebrovascular Disorders ... and treatment of strokes. In the new 6th edition, ... E. Steve Roach of Ohio State University School of Medicine, ... Biller, chairman of the Department of Neurology at Loyola ...
Cached Medicine News:Health News:Jewish Board of Family and Children's Services Welcomes New Board President, Tony Mann 2Health News:Simple Concussion Test Measures Reaction Time 2Health News:Drug for advanced kidney cancer shrinks tumors prior to surgery 2Health News:Drug for advanced kidney cancer shrinks tumors prior to surgery 3Health News:Elizabeth Colston, MD, PhD, of CONNEXION Healthcare, Honored as 'Rising Star' by Healthcare Businesswomen's Association 2Health News:Elizabeth Colston, MD, PhD, of CONNEXION Healthcare, Honored as 'Rising Star' by Healthcare Businesswomen's Association 3Health News:Bilingualism Might Begin in the Womb 2
The O.R. Special Protective Apron is now available with an attached Thyroid Collar. The Thyroid Collar is held on with velcro so it adjusts to fully protect the neck. This Apron with Collar is availa...
The NexGen CR femoral component is intended for patients who, in the physician's judgement, have good bone stock and whose ligaments provide adequate mediolateral, anteroposterior, and varus/valgus s...
StelKast's Proven™ Knee System is a long term high quality solution based on a clinically proven and successful design....
... manufacturers focus attention on implant design, one ... Profix Total Knee System seeks to establish ... system and the tools to implant them. ... recognized for innovation in total knee instrumentation, ...
Medicine Products: